Absci to participate in the ubs medtech, tools and genomics summit 2023

Vancouver, wash. and new york, aug. 01, 2023 (globe newswire) -- absci corporation (nasdaq: absi), a generative ai drug creation company, today announced the company will be participating in the upcoming ubs medtech, tools and genomics summit 2023 in dana point, ca.
ABSI Ratings Summary
ABSI Quant Ranking